Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...
Salvato in:
| Autori principali: | Fakiruddin, Kamal Shaik, Ghazalli, Nadiah, Moon, Nian Lim, Zakaria, Zubaidah, Abdullah, Syahril |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
MDPI
2018
|
| Accesso online: | http://psasir.upm.edu.my/id/eprint/74939/1/ijms-19-02188.pdf |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|
Documenti analoghi
-
Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
di: Shaik M Fakiruddin, Shaik Ahmad Kamal
Pubblicazione: (2021) -
Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell
di: Shaik M Fakiruddin, Shaik Ahmad Kamal
Pubblicazione: (2021) -
Anti-tumour efficacy of human mesenchymal stem cell expressing trail on lung cancer cell lines-derived cancer stem cell /
di: Shaik Ahmad Kamal Shaik M Fakiruddin, -
Chemo-sensitization of CD133+ cancer stem cell enhances the effect of mesenchymal stem cell expressing TRAIL in non-small cell lung cancer cell lines
di: Fakiruddin, Kamal Shaik, et al.
Pubblicazione: (2021) -
Targeting of CD133+ cancer stem cells by mesenchymal stem cell expressing TRAIL reveals a prospective role of apoptotic gene regulation in non-small cell lung cancer
di: Shaik M. Fakiruddin, Shaik Ahmad Kamal, et al.
Pubblicazione: (2019)
